Publication | Closed Access
The PROSIT-BIO Cohort
126
Citations
28
References
2017
Year
Although no direct comparison was performed, preliminary data on efficacy and safety of CT-P13 were in line with those of infliximab.
| Year | Citations | |
|---|---|---|
Page 1
Page 1